ABSTRACT
i.e. desipramine and nortriptyline.
Arieff (I g66) conducted a clinical study, but did not find any difference between the two drugs, and stated â€oe¿ However, the improvement was never as striking or as rapid as when imipramine or amitriptyline was effective. â€˜¿ â€˜¿ Steward and Mitchell ( @ 966) in a double-blind controlled study also found no difference between the two drugs. The purpose of the present trial was to compare the speed of onset of action and overall efficacy of desipramine and nortriptyline in depressive illness under controlled conditions.
METHODS

Selection ofPatientsfor the Trial
All the cases included in the trial were in-patients in St.
Francis Hospital, Haywards Heath, Sussex. They had been diagnosed as having a primary depressive illness, had not received electric convulsion therapy during the previous three months and had had no anti-depressive drug treatment during the previous six weeks. No distinc tion between endogenous and reactive types of depression was attempted.
Patients showing gross retardation or extremeagitation, and those inwhom therisk ofsuicide was considerable, were excluded. Nevertheless a number of the patients included were quite severely depressed.
Design of Trial
Identical white tablets of desipramine 25 mg. or placebo and identical pink tablets of nortriptyline 25 mg. or placebo were put up in bottles of 170, each bottle being numbered with red or black labels. Each patient was given two bottles (one black and one red label) and an equal number of tablets from each bottle was administered.
The distribution of desiprainine and nortriptyline was in accordance with a random code which was not known to the clinical or nursing staff during the period of the trial. Thus the trial was double blind but no cross-over was attempted. At the last assessment a clinical rating was also made and designated greatly improved, improved, no change or worse.
Side effects were recorded as having occurred only when they were either volunteered by the patients themselves or observed by the supervising staff.
RESULTs
Thirty-six patients entered the trial, but six failed to complete it. Of the 30 subjects completing the trial, i8 were male and i 2 female. They varied in age from 20 to 74 years.
On opening the code it was found that i 2 cases had received desipramine and 18 nortriptyline. The average age of patients in the desipramine group was 52 . @ yeai@@ and in the nortriptyline group 53 .
years. Of the I 2 cases in the desipramine group 8 were male and 4 female. Of the i8 patients in the nortrip tyline group I0 were male and 8 female. Thus the two groups were similar with regard to age and sex.
Response to Treatment a. Mean total score: The mean total scores at each assessment for desipramine and nortriptyline did not show any difference between the two drugs.
b. Global rating:In addition to scoring,patients
were also rated at the last assessment as to whether they were greatly improved, improved, no change or Nortriptyline showed better results on anxiety from the tenth day onwards as compared with desipramine. The differences were statistically significant on the tenth day (p< .025), being maximum on the fourteenth day (p < . o I). At the end of three weeks, however, nortriptyline was still superior to desi pramine, but the differences were not signifIcant statistically.
Nortriptyline had done better than desipramine in relieving agitation on the fourteenth day, and the difference was significant statistically (p< â€¢¿ o25), but the final assessment scores showed that both drugs were more or less equally effective in reducing agitation.
Side Effects
The side effects reported were drowsiness, dry mouth, dizziness, hypotension, bowel symptoms and paraesthesiae. Included here are only those side effects which were either volunteered by the patient himself or observed by the supervising staff. They were more marked with desipramine than nortriptyline. These occurred on maximum doses and the majority were multiple, but none of these was serious.
Among the patients on nortriptyline the commonest side effects were drowsiness and dry mouth, whereas dizziness, hypotension and bowel symptoms were common in the desipraminegroup. Paraesthesiae were reported by only one patient who was in the desipramine group. One of the patients whilst on nortriptyline developed general convulsions of the grand ma! type, and serial EEGs showed a consistent abnormality of a general type.
CONCLUSIONS
It is true that from the symptom study, it appears that desipramine relieves depression sooner than nortriptyline (7th day), and nortriptyline is better in relieving agitation and anxiety on the 14th day and anxiety on the ,oth day as well. On the other hand, there are no differences at the end of 2 i days. depressed mood, whereas nortriptyline showed better results in controlling anxiety and agitation. Side effects were significantly more marked with desi pramine, but were of trivial nature and most of them disappeared on reduction of the dose.
